Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month.

Neurologic and Orthopedic Institute of Chicago Offer Complimentary Brain Scans, Oct 26 & 27, as Part of Clinical Study.

CHICAGO, Oct. 19 /PRNewswire/ --

 
  What:          Women diagnosed with HER-2 positive Stage III or Stage IV 
                 breast cancer are eligible to receive an MRI of the brain 
                 at no charge as part of a clinical trial.  HER2 is a breast 
                 cancer that tests positive for a protein called human 
                 epidermal growth factor receptor-2 (HER2), which promotes 
                 the growth of cancer cells.  Studies have shown that in as 
                 many as 30 percent of breast cancer patients have a 
                 metastasis in the brain.  As part of the screening 
                 protocol, participants will undergo a MRI of the brain. The 
                 cost of the MRI is covered by the clinical trial. 
 
  Who:           Patients who qualify must have an initial primary diagnosis 
                 of high risk and/or HER-2 positive breast cancer.  They 
                 must be at least 18 years and should not participate if 
                 they are pregnant. 
 
  When:          Friday, October 26th, 1 p.m. to 9 p.m. 
                 Saturday, October 27th, 8 a.m. to 5 p.m. 
 
  Where:         Neurologic and Orthopedic Institute of Chicago 
                 4501 N. Winchester, Chicago 
 
  Cost:          The brain MRI is free of charge to the patient. 
 
  Background:    The Chicago Institute of Neurosurgery and Neuroresearch 
                 (CINN) Medical Group will use information from the 
            ...